Factory 99% Rivaroxaban Powder CAS 366789-02-8 Antithrombotic Rivaroxaban

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A360
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Rivaroxaban
• CAS: 366789-02-8
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 100g
• Function: Antithrombotic
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Rivaroxaban
Appearance	White Powder
CAS NO.	366789-02-8
Molecular Formula	C19H18ClN3O5S
Storage	Keep in a cool, dry, dark location

 

Rivaroxaban is an oral anticoagulant drug developed jointly by Bayer AG and Johnson & Johnson. It is a potent, selective, and direct inhibitor of factor Xa, which plays a crucial role in the coagulation process.

 

 

1. Postoperative Thromboprophylaxis: Rivaroxaban is used to prevent venous thromboembolism (VTE) in adult patients after total hip replacement (THR) or total knee replacement (TKR) surgery.
2. Atrial Fibrillation: It is also indicated for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
3. Venous Thromboembolism Treatment: Additionally, rivaroxaban is used for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as to reduce the risk of recurrent DVT and PE.

1. Inhibition of Factor Xa: Rivaroxaban selectively inhibits factor Xa, thereby interrupting both the intrinsic and extrinsic pathways of the coagulation cascade, and inhibiting the production of thrombin and the formation of blood clots.
2. Anticoagulant Effect: By inhibiting factor Xa, rivaroxaban exerts an anticoagulant effect, reducing the risk of thrombosis and embolism.
3. Oral Bioavailability: Rivaroxaban has high oral bioavailability, allowing for effective anticoagulation with oral administration.